The Isabelle Musy Prize for Women Entrepreneurs in Science and Technology
Worth CHF 50,000, it aims to encourage women’s entrepreneurship in the fields of science and technology. This prize is open to women who have graduated from a higher education institution in French-speaking Switzerland and Ticino. Please note: the deadline for applications is 25 March! For further information on eligibility criteria and deadlines: Website of the […]
European Alliance dedicated to accelerating new concepts in HIV Vaccine research
The European Commission has granted over 22 million Euros to the European HIV Vaccine Alliance (EHVA) to develop a multidisciplinary platform to evaluate novel preventive and therapeutic vaccines. The grant is supplemented with additional 6 million Euros from the Swiss government for the Swiss project partners. For more information: EHVA – press release EN Communiqué […]
Season’s greetings
Business concept training
The direction of the University of Lausanne supports the development of entrepreneurship especially among its students and its researchers from all faculties. The university offers you the opportunity to take part in the next Business Concept Training supported by the CTI (Commission for Technology and Innovation). Are you inspired to create or join a start-up? Are you keen to acquire a first comprehensive skill set to make you operational and effective in a company? Are you looking for opportunities to go out of your […]
PERLAwards: Entrepreneurs, make yourselves stand out
A financial reward and greater visibility for your business. The deadline for submitting your application is 8 January 2016 at 12 noon. Find out more
Charity and academic collaboration aims to find drug treatment for lymphoma
London, UK, Lausanne, Switzerland, 24 September 2015, MRC Technology and the University of Lausanne are collaborating to find new drug treatments for diffuse large B cell lymphoma, the most common type of non-Hodgkin lymphoma. MALT1 (Mucosa-associated lymphoid tissue lymphoma translocation protein 1), an immunomodulatory enzyme, is required for the effective triggering of an immune response. […]
InnoPACTT: a financial support to create your start-up
Autumn CALL 2015 You are a UNIL-CHUV scientist and would like to create a start-up and need a financial support to start Apply for a one-year InnoTREK grant to launch your UNIL-CHUV spin-off! PACTT, Technology Transfer Office of UNIL-CHUV, is calling for start-up projects for the InnoTREK grant, part of InnoPACTT, a financial fund to accelerate innovation and UNIL-CHUV […]
Bioinnovation Day 2015, CHUV Lausanne: News from Life Sciences Research
Article written by Nicole Regier and Thi-Nhu Y Hoang posted July 6, 2015 in Geneva Business News On June 23rd, the seventh edition of Bioinnovation Day was held at the CHUV in Lausanne. Bioinnovation Day provides a platform for scientists and start-ups to present their life science projects to potential investors and partners from the […]
PACTT announces a license agreement and development collaboration between CHUV and Biocompatibles
PACTT is pleased to announce that CHUV has entered into a license agreement with Biocompatibles, part of specialist healthcare group BTG International, focusing on the treatment of liver tumors, severe blood clots, varicose veins and advanced emphysema. The agreement covers know-how and a patent protected, sustained release technology as well as sustained release drug product […]
News from the InnoPACTT Fund: Two InnoTREK grants for CHUV researchers
Two innovative projects from the 2015 spring call have been awarded the InnoTREK grant, a financial support that will allow the laureats to mature their ideas towards a start-up project. Hosted by Professor Buclin, Division of Clinical Pharmacology at the CHUV, Séverine Petitprez will further develop the software EzeCHiel that will assist physicians in monitoring […]